Spotted Fever Rickettsial Antigens
Spotted Fever Rickettsial Antigens
批准号:
7754595
负责人:
DAVID H WALKER
金额:
$39.46万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-30 至 2014-08-31
关键词:
AccountingAcuteAdoptive TransferAgonistAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAntigen-Presenting CellsAntigensApoptosisBacteriaBacterial InfectionsBiological AssayBone MarrowBrainCD4 Positive T LymphocytesCD8B1 geneCell CommunicationCell LineCell physiologyCellsCenters for Disease Control and Prevention (U.S.)Coculture TechniquesCytotoxic T-LymphocytesDendritic CellsDendritic cell activationDoseEffector CellEndothelial CellsEnzyme-Linked Immunosorbent AssayEnzymesFailureFeverFlow CytometryFrequenciesFutureGoalsGrowthHigh Pressure Liquid ChromatographyHost DefenseHumanImmuneImmune responseImmunityImmunosuppressionImmunosuppressive AgentsIn VitroInfectionInfection ControlInterferon Type IIInterleukin-10Interleukin-12Interleukin-2InterruptionKnockout MiceLeadLifeLigandsLigationLuciferasesLungMeasurementMediatingMononuclearMusMyelogenousNatural Killer CellsOutcomePathogenesisPathway interactionsPhenotypePlaque AssayProductionReceptor SignalingRecording of previous eventsReporterReportingResearchResistanceReverse TranscriptionRickettsiaRickettsia InfectionsRocky Mountain Spotted FeverRoleSalivaSpleenSpottingsStagingStaining methodStainsSystemT-Cell ProliferationT-LymphocyteTLR2 geneTLR3 geneTLR4 geneTicksTimeTissuesToll-like receptorsTryptophanTryptophan 2,3 DioxygenaseWorkchemokinecytokinecytotoxicdepressiondesignenzyme linked immunospot assayhuman datain vivolymphocyte proliferationmRNA Expressionmacrophagemicrobialnovelpublic health relevancereceptorresearch studyresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Severe spotted fever rickettsioses are life-threatening, tick-borne, emerging and re-emerging human infections caused by obligately intracellular Rickettsia including R. conorii and R. rickettsii. Excellent animal models and the available human data reveal the critical importance of IFN-gamma, CD8 cytotoxic T lymphocytes, dendritic cells (DCs) and NK cells in host protective immunity against Rickettsia. Evidence for human rickettsial infection-associated immunosuppression is supported by remarkable suppression of lymphocyte proliferation and IL-2 and IFN-gamma production by IL-10 producing CD4+CD25+ T regulatory cells in acute fatal murine spotted fever rickettsiosis compared to self-limited infection. It remains unclear why the host defense system fails to control bacterial infection in fatal rickettsiosis. The long-term goal of this research is to better understand the immune regulatory mechanisms involved in the inability of the host defense system to control infection in severe spotted fever rickettsiosis. The objective of this proposal is to determine the mechanisms by which DCs mediate defective innate and suppressed adaptive immune responses involving T regulatory 1 cells, which may lead to fatal rickettsial infection. Our specific aim 1 is to determine the key effect of impaired DC-NK cell cross talk on promoting a defective innate immune response in severe spotted fever rickettsiosis. We will compare the defective DC-NK cell cross talk in susceptible mice, which causes progressively increased bacterial loads, with efficient DC-NK cell interaction in resistant mice, which lead to clearance of bacteria during the innate response. Our specific aim 2 is to determine the role of immunoregulatory molecules such as PD-1/PD-L and indoleamine 2,3-dioxygenase (IDO) or cytokines such as IL-10 expressed or produced by DCs and/or T regulatory cells in suppression of T cell responses during severe spotted fever rickettsiosis. Toll-like receptors (TLRs), cytokines and chemokines that mediate the DC-NK cell interaction in specific aim 1, and the role of interactions of DCs with T regulatory cells in mediating suppressed protective effector type-1 T cells and/or apoptosis via suppressive cytokines and/or regulatory molecules including PD-1/PD-L and IDO in severe spotted fever rickettsiosis in specific aim 2 will be investigated using in vivo and in vitro approaches including flow cytometry, ELISPOT, ELISA, RT- or real time PCR, mouse TLR PCR array, immunohistochemical staining, plaque assay, HPLC as well as adoptive transfer, depletion of immune molecules and knockout mice. PUBLIC HEALTH RELEVANCE In recent years the number of cases of Rocky Mountain spotted fever, the most lethal rickettsial disease known, reported to the CDC has reached the highest level in history. This project is designed to determine what components of the immune response are responsible for failure to control bacterial growth in fatal infections to allow future immunomodulatory treatment to enhance survival.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8392057
-
项目类别:
-
资助金额:$22.95万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8377041
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8377034
-
项目类别:
-
资助金额:$58.39万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8377037
-
项目类别:
-
资助金额:$62.07万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Vector-host-pathogen interface in monocytotropic ehrlichiosis
-
批准号:8495268
-
项目类别:
-
资助金额:$17.98万
-
财政年份:2012
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:8233011
-
项目类别:
-
资助金额:$60.26万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:8233007
-
项目类别:
-
资助金额:$72.59万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8233008
-
项目类别:
-
资助金额:$65.25万
-
财政年份:2011
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:8042570
-
项目类别:
-
资助金额:$93.69万
-
财政年份:2010
-
负责人:DAVID H WALKER
-
依托单位:
Administrative Core
-
批准号:7676462
-
项目类别:
-
资助金额:$71.89万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Developmental Research Plan
-
批准号:7676511
-
项目类别:
-
资助金额:$72.83万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Career Development and Training Program
-
批准号:7676456
-
项目类别:
-
资助金额:$72.2万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
Western Regional Center of Excellence for Biodefense and Emerging Infectious Dise
-
批准号:7908303
-
项目类别:
-
资助金额:$93.23万
-
财政年份:2009
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7716083
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
EXPERIMENTAL INFECTION OF THE MARMOSET WITH LASSA VIRUS
-
批准号:7716110
-
项目类别:
-
资助金额:$0.27万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER BIVALENT VACCINE EFFICACY IN MARMOSETS
-
批准号:7716131
-
项目类别:
-
资助金额:$0.65万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7716059
-
项目类别:
-
资助金额:$2.07万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
WRCE Administrative Core
-
批准号:7649683
-
项目类别:
-
资助金额:$60.47万
-
财政年份:2008
-
负责人:DAVID H WALKER
-
依托单位:
REGION VI RCE - NONHUMAN PRIMATE CORE
-
批准号:7562433
-
项目类别:
-
资助金额:$14.5万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位:
LASSA FEVER VACCINE EFFICACY IN MARMOSETS
-
批准号:7562462
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2007
-
负责人:DAVID H WALKER
-
依托单位:
海外基金